Biolidics Limited

Equities

8YY

SGXE89830751

Advanced Medical Equipment & Technology

Market Closed - Singapore S.E. 05:04:21 2024-05-24 am EDT 5-day change 1st Jan Change
0.012 SGD +9.09% Intraday chart for Biolidics Limited +9.09% -14.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bioldics' Financial Controller Steps Down MT
Biolidics Limited Announces the Resignation of Siu Yeung Sau as Financial Controller CI
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1 MT
Biolidics' Q1 Loss Widens as Revenue Slumps; Stock Surges 20% MT
Biolidics Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Biolidics Flags Cybersecurity Incident; Shares Surge 10% MT
Biolidics Appoints President MT
Biolidics Limited Announces Board Changes CI
Biolidics Limited Announces the Redesignation of Zhu Hua from Non-Executive Non-Independent Director to Executive Director CI
Singapore Shares Fall at Market Close; Biolidics Up 9% MT
Biolidics’ Loss Narrows in 2023 as Revenue Slumps 47%; Shares Surge 9% MT
Biolidics to Issue Shares Worth Over SG$360,000 to New Director MT
Biolidics Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Biolidics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Biolidics Limited Announces the Change of its Registered Office Address CI
Biolidics Issues Over 87 Million Shares to Sponsor, Investor MT
Biolidics Obtains Bourse's Nod to List Over 87 Million Shares MT
Biolidics to Issue SG$50,000 of Shares to Sponsor as Partial Payment of Professional Fee MT
Biolidics to Raise Over SG$1 Million from Share Placement MT
Biolidics Ropes in Evolve Capital Advisory as Sponsor MT
Biolidics Limited Appoints Zhu Hua as A Non-Executive Non-Independent Director CI
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics MT
Biolidics Issues 98.5 Million Shares Under Subscription Agreement; Shares Jump 8% MT
Biolidics Obtains Regulatory Nod to List 98.5 Million Shares Under Subscription Agreement MT
Biolidics Limited Announces Board Changes CI
Chart Biolidics Limited
More charts
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 8YY Stock
  4. News Biolidics Limited
  5. Singapore Shares Fall at Market Close; Biolidics Up 9%